| Shoprite Pharmacy Dept #533 | |
| 2555 Pennington Rd, Pennington, New Jersey 08534 | |
| (609) 737-0606 |
| Name | Shoprite Pharmacy Dept #533 |
|---|---|
| Organization Name | Saker Shoprites Inc |
| Location | 2555 Pennington Rd, Pennington, New Jersey 08534 |
| Type | Pharmacy |
| Phone | (609) 737-0606 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Isis Pharmaceuticals, Inc. announced today that it has earned a $10 million milestone payment from Biogen Idec related to the initiation of investigational new drug (IND)-supporting studies of ISIS-BIIB3Rx. ISIS-BIIB3Rx is a recently identified development candidate designed to inhibit an undisclosed target to treat a neurodegenerative disease.
The findings reveal that the variant has considerably higher transmissibility and immune escape potential than previously circulating variants and that it can increase the infection fatality rate by 62% - 82% among older adults. The study is currently available on the medRxiv* preprint server.
Kaiser Health News staff writer Jenny Gold writes about the confusion currently surrounding consumers. "Every day, dozens of confused, laid-off workers call the COBRA Help Center in Long Island, N.Y., a small private company which administers COBRA group health insurance plans.
The Center for Medicine in the Public Interest (CMPI) today launched BigGovHealth.org, a new initiative to expose the consequences of greater government control in health care.
The antibiotic minocycline may revolutionize the treatment of strokes. A new study, published in the open access journal BMC Neuroscience, describes the safety and therapeutic efficacy of the drug in animal models.
› Verified 3 days ago
| NPI Number | 1073629499 |
| Organization Name | SAKER SHOPRITES INC |
| Doing Business As | SHOPRITE PHARMACY #533 |
| Type | Pharmacy |
| Address | 2555 Pennington Rd, Pennington, NJ 08534 |
| Phone Number | 609-737-0606 |
News Archive
Isis Pharmaceuticals, Inc. announced today that it has earned a $10 million milestone payment from Biogen Idec related to the initiation of investigational new drug (IND)-supporting studies of ISIS-BIIB3Rx. ISIS-BIIB3Rx is a recently identified development candidate designed to inhibit an undisclosed target to treat a neurodegenerative disease.
The findings reveal that the variant has considerably higher transmissibility and immune escape potential than previously circulating variants and that it can increase the infection fatality rate by 62% - 82% among older adults. The study is currently available on the medRxiv* preprint server.
Kaiser Health News staff writer Jenny Gold writes about the confusion currently surrounding consumers. "Every day, dozens of confused, laid-off workers call the COBRA Help Center in Long Island, N.Y., a small private company which administers COBRA group health insurance plans.
The Center for Medicine in the Public Interest (CMPI) today launched BigGovHealth.org, a new initiative to expose the consequences of greater government control in health care.
The antibiotic minocycline may revolutionize the treatment of strokes. A new study, published in the open access journal BMC Neuroscience, describes the safety and therapeutic efficacy of the drug in animal models.
› Verified 3 days ago
| NPI Number | 1962557645 |
| Organization Name | SHOPRITE PHARMACY OF PENNINGTON |
| Type | Pharmacy |
| Address | 2555 Pennington Rd, Pennington, NJ 08534 |
| Phone Number | 609-737-0606 |
News Archive
Isis Pharmaceuticals, Inc. announced today that it has earned a $10 million milestone payment from Biogen Idec related to the initiation of investigational new drug (IND)-supporting studies of ISIS-BIIB3Rx. ISIS-BIIB3Rx is a recently identified development candidate designed to inhibit an undisclosed target to treat a neurodegenerative disease.
The findings reveal that the variant has considerably higher transmissibility and immune escape potential than previously circulating variants and that it can increase the infection fatality rate by 62% - 82% among older adults. The study is currently available on the medRxiv* preprint server.
Kaiser Health News staff writer Jenny Gold writes about the confusion currently surrounding consumers. "Every day, dozens of confused, laid-off workers call the COBRA Help Center in Long Island, N.Y., a small private company which administers COBRA group health insurance plans.
The Center for Medicine in the Public Interest (CMPI) today launched BigGovHealth.org, a new initiative to expose the consequences of greater government control in health care.
The antibiotic minocycline may revolutionize the treatment of strokes. A new study, published in the open access journal BMC Neuroscience, describes the safety and therapeutic efficacy of the drug in animal models.
› Verified 3 days ago
News Archive
Isis Pharmaceuticals, Inc. announced today that it has earned a $10 million milestone payment from Biogen Idec related to the initiation of investigational new drug (IND)-supporting studies of ISIS-BIIB3Rx. ISIS-BIIB3Rx is a recently identified development candidate designed to inhibit an undisclosed target to treat a neurodegenerative disease.
The findings reveal that the variant has considerably higher transmissibility and immune escape potential than previously circulating variants and that it can increase the infection fatality rate by 62% - 82% among older adults. The study is currently available on the medRxiv* preprint server.
Kaiser Health News staff writer Jenny Gold writes about the confusion currently surrounding consumers. "Every day, dozens of confused, laid-off workers call the COBRA Help Center in Long Island, N.Y., a small private company which administers COBRA group health insurance plans.
The Center for Medicine in the Public Interest (CMPI) today launched BigGovHealth.org, a new initiative to expose the consequences of greater government control in health care.
The antibiotic minocycline may revolutionize the treatment of strokes. A new study, published in the open access journal BMC Neuroscience, describes the safety and therapeutic efficacy of the drug in animal models.
› Verified 3 days ago
Eastern Pedorthics Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 70 Route 31 South, Pennington, New Jersey 08534 Phone: (609) 737-7701 | |
Lincare Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1589 Reed Rd, Pennington, New Jersey 08534 Phone: (609) 818-9202 | |
Shoprite Pharmacy Dept #533 Type: Pharmacy Location: 2555 Pennington Rd, Pennington, New Jersey 08534 Phone: (609) 737-0606 | |
Stop & Shop Pharmacy #850 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 800 Denow Rd F, Pennington, New Jersey 08534 Phone: (609) 737-9185 | |
Walgreens #19579 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 25 Route 31 S, Pennington, New Jersey 08534 Phone: (609) 737-0900 |